A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
The purpose of this study is to determine whether nivolumab monotherapy or in combination with Standard of care (SOC) therapies will provide clinical benefit (i.e., PFS, OS, and DOR) without unacceptable toxicity in advanced Non-Small Cell Lung Cancer patients.
Checked against the public recordLast updated May 6, 2021 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Sponsor
- Bristol-Myers Squibb
- Interventions being studied
- Drug: Nivolumab; Drug: Bevacizumab; Drug: Pemetrexed; Other: Best Supportive Care; Drug: nab-Paclitaxel; Drug: Paclitaxel; Drug: Docetaxel; Drug: Gemcitabine; Drug: Erlotinib; Drug: Crizotinib; Drug: Carboplatin
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Histologically confirmed locally advanced or stage IV NSCLC * Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2 * Tumor tissue sections must be available for biomarker evaluation Exclusion Criteria: * Untreated or active/progressing Central Nervous system (CNS) metastases * Active, known or suspected autoimmune disease * Known history of testing positive for HIV or AIDS * Active or chronic infection of hepatitis B virus or hepatitis C
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Alabama OncologyBirmingham, Alabama
- Southern Cancer Center PcMobile, Alabama
- Arizona Oncology Assoc, Pc-HalGlendale, Arizona
- Northern Arizona Hematology & Oncology AssociatesSedona, Arizona
- Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) HopeTucson, Arizona
- Arizona Clinical Research Center, Inc.Tucson, Arizona
- Comprehensive Blood And Cancer CenterBakersfield, California
- St. Joseph Heritage Medical GroupFullerton, California
- Scripps Cancer CenterLa Jolla, California
- UCLA Hematology/Oncology ClinicLos Angeles, California
- Coastal Integrative Cancer CareSan Luis Obispo, California
- Central Coast Med OncologySanta Maria, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 6, 2021. Always confirm current availability with the study team.